OBJECTIVE -To determine whether middle-aged premenopausal women with type 1 diabetes had more self-reported fractures and lower bone mineral density (BMD) compared with nondiabetic women.RESEARCH DESIGN AND METHODS -Participants were premenopausal women aged 35-55 years with type 1 diabetes (n ϭ 67; 32.2 Ϯ 5.3 years duration) and without diabetes (n ϭ 237). Total hip, femoral neck, whole-body, and spine BMD were measured by dual X-ray absorptiometry. Calcaneal broadband ultrasound attenuation (BUA) was assessed with quantitative ultrasound.RESULTS -Women with type 1 diabetes were more likely to report a fracture after age 20 years compared with nondiabetic women (33.3 vs. 22.6%; age-adjusted odds ratio 1.89 [95% CI 1.02-3.49]). Type 1 diabetes was associated with lower total hip BMD (0.890 vs. 0.961 g/cm 2 ; P Ͻ 0.001), femoral neck BMD (0.797 vs. 0.847 g/cm 2 ; P ϭ 0.001), whole-body BMD (1.132 vs. 1.165 g/cm 2 ; P Ͻ 0.01), and lower calcaneal BUA (71.6 vs. 84.9 dB/MHz; P Ͻ 0.001) after multivariate adjustment. BMD was 3-8% lower in type 1 diabetic compared with control women and calcaneal BUA was 15% lower. Spine BMD and biomarkers of bone remodeling were not significantly different between groups. In the type 1 diabetic women, reduced monofilament detection and blindness were both associated with lower BMD.CONCLUSIONS -Lower BMD in premenopausal women with type 1 diabetes may substantially increase their risk of developing osteoporosis after menopause. Type 1 diabetic women should be targeted for osteoporosis screening and possible fracture prevention as they transition through menopause.
Diabetes Care 29:306 -311, 2006T he impact of the menopause transition on osteoporosis in type 1 diabetes is not well established. The Nord-Trodelag Health Survey (1) and the Iowa Women's Health Survey (2) found a 7-and 12-fold increase in hip fractures, respectively, in older type 1 diabetic women. Type 1 diabetes was associated with ϳ10% lower bone mineral density (BMD) compared with nondiabetic adults (3-10) in most but not all studies (11-13), though many include only small numbers of cases and lack adjustment for traditional osteoporosis risk factors (e.g., lower body weight and smoking). Few investigations (3,5,13) of type 1 diabetes and BMD focus exclusively on middleaged and postmenopausal women, those at highest risk for osteoporosis and fractures.Evidence exists for the role of diabetes complications of peripheral neuropathy (6,12,14,15), retinopathy (14,16 -18), and nephropathy (14,17,19) in osteoporosis. Peripheral measures of bone, such as calcaneal quantitative ultrasound (QUS) (20,21), could be more affected by peripheral vascular disease or peripheral neuropathy (15). Worse glycemic control in type 1 diabetes was generally not related to lower BMD (4 -12,17,22). Genetic variants in the vitamin D receptor (8) or collagen type 1 ␣-1 (9) are possibly associated with low BMD in type 1 diabetes. Decreased BMD in middle-aged type 1 diabetic women could be due to increased bone turnover (16,23,24), but recent studie...